S. Parker Singleton, Brooke L. Sevchik, Simon N. Vandekar, Eric C. Strain, Sandeep M. Nayak, Robert H. Dworkin, J. Cobb Scott, Theodore D. Satterthwaite
{"title":"临床致幻剂研究中活证据合成的创举","authors":"S. Parker Singleton, Brooke L. Sevchik, Simon N. Vandekar, Eric C. Strain, Sandeep M. Nayak, Robert H. Dworkin, J. Cobb Scott, Theodore D. Satterthwaite","doi":"10.1038/s44220-024-00373-4","DOIUrl":null,"url":null,"abstract":"Renewed interest in psychedelics as treatments for mental disorders has recently emerged, but substantial challenges remain in obtaining evidence from available data to inform clinical decision-making. This Comment explores the current landscape of clinical psychedelic research, highlighting the need for a systematic approach to evidence synthesis.","PeriodicalId":74247,"journal":{"name":"Nature mental health","volume":"3 1","pages":"3-5"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An initiative for living evidence synthesis in clinical psychedelic research\",\"authors\":\"S. Parker Singleton, Brooke L. Sevchik, Simon N. Vandekar, Eric C. Strain, Sandeep M. Nayak, Robert H. Dworkin, J. Cobb Scott, Theodore D. Satterthwaite\",\"doi\":\"10.1038/s44220-024-00373-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Renewed interest in psychedelics as treatments for mental disorders has recently emerged, but substantial challenges remain in obtaining evidence from available data to inform clinical decision-making. This Comment explores the current landscape of clinical psychedelic research, highlighting the need for a systematic approach to evidence synthesis.\",\"PeriodicalId\":74247,\"journal\":{\"name\":\"Nature mental health\",\"volume\":\"3 1\",\"pages\":\"3-5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-01-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature mental health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.nature.com/articles/s44220-024-00373-4\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature mental health","FirstCategoryId":"1085","ListUrlMain":"https://www.nature.com/articles/s44220-024-00373-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
An initiative for living evidence synthesis in clinical psychedelic research
Renewed interest in psychedelics as treatments for mental disorders has recently emerged, but substantial challenges remain in obtaining evidence from available data to inform clinical decision-making. This Comment explores the current landscape of clinical psychedelic research, highlighting the need for a systematic approach to evidence synthesis.